Well, he was left with a sound science, a product, AT-014, possibly near conditional approval, a PIII for cervical cancer and more. When I see what we have in the pipeline, it's unbelievable that the share price is so low. Many missteps have been made along the way. I hope Big Tony can turn it around. I would be lying if I said I wasn't nervous about the Jefferies conference after the way the last one went but hope springs eternal.
News 
Market Data 
Discover 
